Bioequivalence study of two ibuprofen formulations administered intravenously in healthy male volunteers

Clinical Drug Investigation

Volumn 24, Issue 12, 2004, Pages 739-747

  Chassard, D ^a   Geneteau, A ^b   Gualano, V ^b   Brault, M ^b  

^a Aster Cephac   (France)

^b CEPHAC Europe   (France)

Author keywords

[No Author keywords available]

Indexed keywords

IBUPROFEN; IBUPROFEN LYSINE;

ADULT; AREA UNDER THE CURVE; ARTICLE; BIOEQUIVALENCE; BURNING SENSATION; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CREATININE CLEARANCE; CROSSOVER PROCEDURE; DRUG BIOAVAILABILITY; DRUG BLOOD LEVEL; DRUG DOSAGE FORM; DRUG HALF LIFE; DRUG TOLERABILITY; HEADACHE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN EXPERIMENT; INJECTION PAIN; MALAISE; MALE; NORMAL HUMAN; OTITIS; PATENT DUCTUS ARTERIOSUS; PREMATURITY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SINGLE DRUG DOSE; STATISTICAL ANALYSIS; VOLUNTEER;

EID: 10844219899     PISSN: 11732563     EISSN: None     Source Type: Journal    
DOI: 10.2165/00044011-200424120-00005     Document Type: Article

References (15)

1. Van Overmeire B, Smets K, Lecoutere D, et al. A comparison of ibuprofen and indomethacin for closure of patent ductus arteriosus. N Engl J Med 2000; 343 (10): 674-81
2. Van Overmeire B, Follens I, Hartmann S, et al. Treatment of patent ductus arteriosus with ibuprofen. Arch Dis Child 1997; 76: F179-84
3. Varvarigou A, Bardin C, Beharry K, et al. Early ibuprofen administration to prevent patent ductus arteriosus in premature newborn infants. JAMA 1996; 275 (N7): 539-44
4. Mosca F, Bray M, Lattanzio M, et al. Comparative evaluation of the effects of indomethacin and ibuprofen on cerebral perfusion and oxygenation in preterm infants with patent ductus arteriosus. J Pediatr 1997; 131: 549-54
5. Patel J, Roberts I, Azzopardi D, et al. Randomized double-blind controlled trial comparing the effects of ibuprofen with indomethacin on cerebral hemodynamics in preterm infants with patent ductus arteriosus. Pediatr Res 2000; 47 (1): 36-42
6. Pezzati J. Effects of indomethacin and ibuprofen on mesenteric and renal blood flow in preterm infants with patent ductus arteriosus. Pediatrics 1999 Dec; 135 (6): 733-8
7. Internal CEPHAC Validation Report No. CP005315
8. Internal CEPHAC Method Validation SOP No. 860
9. Hauschke D, Steinijans VW, Diletti E. A distribution-free procedure for the statistical analysis of bioequivalence study. Int J of Clin Pharmacol Ther Tox. 1992; 28: No.2 (72-78), 1992; 30 (Suppl. 1): S37-43
10. Hauschke D, Steinijans VW, Diletti E. A distribution-free procedure for the statistical analysis of bioequivalence study. Int J of Clin Pharmacol Ther Tox. 1992; 28: No.2 (72-78), 1992; 30 (Suppl. 1): S37-43
11. Davies NM. Clinical pharmacokinetics of ibuprofen, the first 30 years. Clin Pharmacokinet 1998; 34 (2): 101-54
12. Jamali F, Singh NN, Pasutto FM, et al. Pharmacokinetics of ibuprofen enantiomers in humans following oral administration of tablets with different absorption rates. Pharm Res 1988; 5 (1): 40-3
13. Jamali F, Mehvar R, Russel AS, et al. Human pharmacokinetics of ibuprofen enantiomers following different doses and formulations: intestinal chiral inversion. J Pharm Sci 1992; 81 (3): 221-5
14. Oliari J, Tod M, Nicolas P, et al. Pharmacokinetics of ibuprofen enantiomers after single and repeated doses in man. Biopharm Drug Dispos 1992; 13: 337-44
15. Hall SD, Rudy AC, Knight PM, et al. Lack of presystemic inversion of (R) to (S)-ibuprofen in humans. Clin Pharmacol Ther 1993, 53 (4): 393-400